CDER Statistical Studies Innovate Measures of Adhesion to Assess Generic Products
Drugs and the technologies used to deliver them evolve rapidly, and methods to evaluate them must be continually adapted to ensure the safety and efficacy of new medicines. An excellent illustration of this process of adaptation is recent work by Center for Drug Evaluation and Research (CDER) statisticians who developed innovative and more efficient ways to evaluate a class of products that deliver drugs via the skin. The improved statistical analysis methods greatly enhance the power of drug development studies to provide conclusive results and have led to revised recommendations in CDER guidances. These revisions enhance the ability to develop high-quality generics of these products. “Traditional” Evaluation of Delivery System Adhesion to Skin Transdermal and topical delivery systems (collectively called TDS) are preparations of drugs that are typically dissolved or suspended in a mixture of components, including adhesives, for application to intact skin. These systems may ...